Book contents
- Ethical and Clinical Complexities in the Treatment of Schizophrenia
- Ethical and Clinical Complexities in the Treatment of Schizophrenia
- Copyright page
- Contents
- Contributors
- Preface
- Part I Neuroscience
- Chapter 1 The Story of Schizophrenia
- Chapter 2 What Is the Neurobiology of Schizophrenia?
- Chapter 3 What Is Schizophrenia?
- Chapter 4 Assessment and Treatment of Anosognosia in Schizophrenia
- Chapter 5 Anosognosia in Schizophrenia
- Chapter 6 How Antipsychotics Work in Schizophrenia
- Chapter 7 Do Antipsychotics Work in People with Schizophrenia?
- Chapter 8 Do Antipsychotic Medications Work?
- Chapter 9 When Do Psychiatric Interventions Work?
- Chapter 10 Medications for Psychosis in People with Schizophrenia
- Chapter 11 Assisted Outpatient Treatment
- Chapter 12 Forensic Assertive Community Treatment
- Chapter 13 Does Compulsory Community Treatment for Discharged Forensic Hospital Patients Work?
- Chapter 14 Early Intervention for Schizophrenia
- Chapter 15 Cardiometabolic Disorders in Persons Living with Schizophrenia
- Part II International Policy Perspectives
- Part III Neuroethics
- Index
- References
Chapter 14 - Early Intervention for Schizophrenia
A Pathway to Improved Clinical Outcomes
from Part I - Neuroscience
Published online by Cambridge University Press: 29 April 2026
Book contents
- Ethical and Clinical Complexities in the Treatment of Schizophrenia
- Ethical and Clinical Complexities in the Treatment of Schizophrenia
- Copyright page
- Contents
- Contributors
- Preface
- Part I Neuroscience
- Chapter 1 The Story of Schizophrenia
- Chapter 2 What Is the Neurobiology of Schizophrenia?
- Chapter 3 What Is Schizophrenia?
- Chapter 4 Assessment and Treatment of Anosognosia in Schizophrenia
- Chapter 5 Anosognosia in Schizophrenia
- Chapter 6 How Antipsychotics Work in Schizophrenia
- Chapter 7 Do Antipsychotics Work in People with Schizophrenia?
- Chapter 8 Do Antipsychotic Medications Work?
- Chapter 9 When Do Psychiatric Interventions Work?
- Chapter 10 Medications for Psychosis in People with Schizophrenia
- Chapter 11 Assisted Outpatient Treatment
- Chapter 12 Forensic Assertive Community Treatment
- Chapter 13 Does Compulsory Community Treatment for Discharged Forensic Hospital Patients Work?
- Chapter 14 Early Intervention for Schizophrenia
- Chapter 15 Cardiometabolic Disorders in Persons Living with Schizophrenia
- Part II International Policy Perspectives
- Part III Neuroethics
- Index
- References
Summary
This chapter explores the transformative potential of early intervention in schizophrenia, emphasizing its role in improving clinical, functional, and social outcomes. Through the poignant case of “Roger,” a man whose life was marked by untreated psychosis, homelessness, and missed opportunities for care, the chapter illustrates the consequences of delayed treatment and fragmented systems. It reviews epidemiological data, the importance of reducing the duration of untreated psychosis (DUP), and the neurobiological rationale for early-phase treatment. Models such as Coordinated Specialty Care (CSC), EPPIC, and Assertive Community Treatment (ACT) are discussed as effective frameworks for delivering comprehensive, multidisciplinary care. The chapter also addresses barriers to early intervention—including stigma, misdiagnosis, access limitations, and systemic inequities—and advocates for integrated, culturally responsive, and person-centered approaches. Ultimately, it calls for a shift in healthcare systems to prioritize early identification and treatment as a moral and clinical imperative.
Keywords
Information
- Type
- Chapter
- Information
- Ethical and Clinical Complexities in the Treatment of SchizophreniaLiberty or Life, pp. 119 - 122Publisher: Cambridge University PressPrint publication year: 2026
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013.Google Scholar
Bighelli, I, Rodolico, A, García-Mieres, H, et al. Psychosocial and psychological interventions for relapse prevention in schizophrenia: A systematic review and network meta-analysis. Lancet Psychiatry. 2021;8(11):969–980. doi:10.1016/S2215- 0366(21)00243-1CrossRefGoogle ScholarPubMed
Birchwood, M, Todd, P, Jackson, C. Early intervention in psychosis: The critical period hypothesis. Br J Psychiatry. 1998;172(33):53–59. doi:10.1192/S000712500029768CrossRefGoogle ScholarPubMed
Cooper, T, Seigler, MD, Stahl, S. Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions. J Psychopharmacol. 2023;37(3):242–247. doi:10.1177/02698811231161243CrossRefGoogle ScholarPubMed
Corrigan, PW. How stigma interferes with mental health care. Am Psychol. 2004;59(7):614–625. doi:10.1037/0003-066X.59.7.614CrossRefGoogle ScholarPubMed
Dieterich, M, Irving, CB, Park, B, Marshall, M. Intensive case management for severe mental illness. Cochrane Database Syst Rev. 2017;1:CD007906. doi:10.1002/14651858.CD007906.pub3Google ScholarPubMed
Dixon, L, McFarlane, WR, Lefley, H, et al. Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatr Serv. 2001;52(7):903–910. doi:10.1176/appi.ps.52.7.903CrossRefGoogle ScholarPubMed
Kahn, RS, Fleischhacker, WW, Boter, H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomized clinical trial. Lancet. 2008;371(9618):1085–1097. doi:10.1016/S0140-6736(08)60486–9CrossRefGoogle Scholar
Kane, JM, Robinson, DG, Schooler, NR, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE Early Treatment Program. Am J Psychiatry. 2016;173(4):362–372. doi:10.1176/appi.ajp.2015.15050632CrossRefGoogle Scholar
Marshall, M, Lewis, S, Lockwood, A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch Gen Psychiatry. 2005;62(9):975–983. doi:10.1001/archpsyc.62.9.975CrossRefGoogle ScholarPubMed
McGorry, PD, Killackey, E, Yung, AR. Early intervention in psychosis: Concepts, evidence and future directions. World Psychiatry. 2008;7(3):148–156.10.1002/j.2051-5545.2008.tb00182.xCrossRefGoogle ScholarPubMed
McGorry, PD, Yung, AR, Phillips, LJ. The “close-in” or ultra high-risk model: A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull. 2002;28(3):485–496. doi:10.1093/oxfordjournals.schbul.a006989Google Scholar
Oluwoye, O, Kriegel, LS, Alcover, KC, McDonell, MG. Racial and ethnic disparities in first-episode psychosis: A review of the literature. Psychiatr Serv. 2021;72(5):567–577. doi:10.1176/appi.ps.202000353Google Scholar
Penttilä, M, Jääskeläinen, E, Hirvonen, N, Isohanni, M, Miettunen, J. Duration of untreated psychosis as a predictor of long-term outcome in schizophrenia: Systematic review and meta-analysis. Br J Psychiatry. 2014;205(2):88–94. doi:10.1192/bjp.bp.113.127753CrossRefGoogle ScholarPubMed
Singh, SP, Grange, T. Measuring pathways to care in first-episode psychosis: A systematic review. Schizophr Res. 2006;81(1):75–82. doi:10.1016/j.schres.2005.09.018CrossRefGoogle ScholarPubMed
U.S. Food and Drug Administration. Clozaril [Prescribing Information]. 2010. www.accessdata.fda.gov/drugsatfda_docs/label/2010/019758s062lbl.pdfGoogle Scholar
U.S. Food and Drug Administration. Frequently asked questions about the Clozapine REMS modification. Published December 21, 2024. Accessed April 30, 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/frequently-asked-questions-clozapine-rems-modificationGoogle Scholar
Accessibility standard: WCAG 2.1 AA
Why this information is here
This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.Accessibility Information
The HTML of this chapter
complies with version 2.1 of the
Web Content Accessibility Guidelines
(WCAG), covering newer accessibility requirements and improved
user experiences and achieves the intermediate
(AA)
level of WCAG compliance, covering a wider range of accessibility requirements.
Content Navigation
Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.
Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.
Reading Order & Textual Equivalents
Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.
Short alternative textual descriptions
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
You get concise descriptions (for images, charts, or media clips), ensuring you do not miss crucial information when visual or audio elements are not accessible.
Full alternative textual descriptions
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.
You get more than just short alt text: you have comprehensive text equivalents, transcripts, captions, or audio descriptions for substantial non‐text content, which is especially helpful for complex visuals or multimedia.
Visual Accessibility
Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.
Structural and Technical Features
ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.